With Alhemo (concizumab-mtci) from Novo Nordisk A/S, a third hemophilia drug in the past eight months has been approved by the U.S. FDA. The once-daily injectable prophylaxis is to prevent or reduce ...
Smiths Group benefits from a high proportion of aftermarket revenue that is sticky and high profit margin. Smiths Group’s balance sheet remains in good financial condition, with net debt of GBP 213 ...